0 NASDAQ Companies - September 8, 2020Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a […]Read More
0 NYSE Companies - September 8, 2020ROYAL DUTCH SHELL PLC SECOND QUARTER 2020 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTSThe Hague, September 8, 2020 – The Board of Royal Dutch Shell plc (“RDS”) today announced the pounds sterling and […]Read More
0 NASDAQ Companies - September 8, 2020WISeKey Reports H1 2020 Results and Launches Digital Transformation StrategyWISeKey Reports H1 2020 Results and Launches Digital Transformation Strategy Bay Street NewsRead More
0 NASDAQ Companies - September 8, 2020Innate Pharma Reports First Half 2020 Financial Results and Business UpdateInnate resumed enrollment of lacutamab TELLOMAK Phase 2 clinical trial for patients with Sézary syndrome and mycosis fungoidesMonalizumab Phase 3 […]Read More
0 NASDAQ Companies - September 8, 2020ObsEva SA to present at the H.C Wainwright 22nd Annual Global Investment Virtual Conference, September 14-16, 2020 Geneva, Switzerland and Boston, MA – September 8, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]Read More
0 NASDAQ Companies - September 8, 2020Uxin Reports Unaudited First Quarter of Fiscal Year 2021 Financial ResultsBEIJING, Sept. 08, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used […]Read More
0 NYSE Companies - September 7, 2020Suncor Energy provides operational and 2020 guidance updateAll financial figures are in Canadian dollars.CALGARY, Alberta, Sept. 07, 2020 (GLOBE NEWSWIRE) — Following the August 14 incident at […]Read More
0 NYSE Companies - September 7, 2020Suncor Énergie fait une mise à jour sur ses activités et ses prévisions pour 2020Tous les montants sont en dollars canadiens.CALGARY, Alberta, 07 sept. 2020 (GLOBE NEWSWIRE) — À la suite de l’incident qui […]Read More
0 NASDAQ Companies - September 7, 2020Albireo to Announce Topline Results from PEDFIC 1 Phase 3 Trial of Odevixibat on September 8, 2020BOSTON, Sept. 07, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel […]Read More
0 TSX Venture News - September 7, 2020Amended Promissory NoteTORONTO, Sept. 07, 2020 (GLOBE NEWSWIRE) — Melior Resources Inc. (TSXV: “MLR”) (“Melior” or the “Company”) today has entered into […]Read More